Desvenlafaxina benzoato

Desvenlafaxina Neuraxpharm 100 MG Comprimidos de Liberacion Prolongada Efg

146,32 mg comprimido de liberación prolongadaSpainMarketedAuthorised 4 Apr 2022

Packs

Pack	Code	Status
DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/PVC/PE/PVDC)	734026
DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/OPA/Al/PVC)	734027

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Desvenlafaxina benzoato

Desvenlafaxina Neuraxpharm 100 MG Comprimidos de Liberacion Prolongada Efg

146,32 mg comprimido de liberación prolongadaSpainMarketedAuthorised 4 Apr 2022

Product informationAsk Osler about it

Packs

Pack	Code	Status
DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/PVC/PE/PVDC)	734026
DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/OPA/Al/PVC)	734027

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Desvenlafaxina benzoato
Strength: 146,32 mg
Dosage form: comprimido de liberación prolongada
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 4 Apr 2022
Registration: 86784
Marketing authorisation holder: Neuraxpharm Spain S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Desvenlafaxina benzoato · 73,16 mg · comprimido de liberación prolongada

Spain

Desvenlafaxina Cinfa 100 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 146,32 mg · comprimido de liberación prolongadaSpain

Desvenlafaxina Cinfa 50 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 73,16 mg · comprimido de liberación prolongadaSpain

Desvenlafaxina Neuraxpharm 50 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 73,16 mg · comprimido de liberación prolongadaSpain

Desvenlafaxina Stada 100 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 146,32 mg · comprimido de liberación prolongadaSpain

Desvenlafaxina Stada 50 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 73,16 mg · comprimido de liberación prolongadaSpain

Exital 100 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 146,32 mg · comprimido de liberación prolongadaSpain

Exital 50 MG Comprimidos de Liberacion Prolongada EfgDesvenlafaxina benzoato · 73,16 mg · comprimido de liberación prolongadaSpain